Managing Malignant Pleural Mesothelioma in the Age of Personalized Medicine: Where Are We and What Is Still Missing?-Reference-Cited by-同舟云学术

Managing Malignant Pleural Mesothelioma in the Age of Personalized Medicine: Where Are We and What Is Still Missing?

Published:2022-11-11 Issue:22 Volume:14 Page:5540
ISSN:2072-6694
Container-title:Cancers
language:en
Short-container-title:Cancers

Author:

Stella Giulia Maria^ORCID,Bortolotto Chandra^ORCID

Abstract

Malignant Mesothelioma (MM) is an aggressive neoplasm of the pleural mesothelium, less frequently peritoneal and exceptionally of the vaginal tunic of the testicle and pericardium [...]

Publisher

MDPI AG

Subject

Cancer Research,Oncology

Link

https://www.mdpi.com/2072-6694/14/22/5540/pdf

Reference6 articles.

1. Affatato, R., Mendogni, P., Del Gobbo, A., Ferrero, S., Ricci, F., Broggini, M., and Rosso, L. Establishment and Characterization of Patient-Derived Xenografts (PDXs) of Different Histology from Malignant Pleural Mesothelioma Patients. Cancers, 2020. 12.

2. Yang, H., Hall, S.R.R., Sun, B., Zhao, L., Gao, Y., Schmid, R.A., Tan, S.T., Peng, R.W., and Yao, F. NF2 and Canonical Hippo-YAP Pathway Define Distinct Tumor Subsets Characterized by Different Immune Deficiency and Treatment Implications in Human Pleural Mesothelioma. Cancers, 2021. 13.

3. Vidergar, R., Balduit, A., Zacchi, P., Agostinis, C., Mangogna, A., Belmonte, B., Grandolfo, M., Salton, F., Biolo, M., Zanconati, F., C1q-HA Matrix Regulates the Local Synthesis of Hyaluronan in Malignant Pleural Mesothelioma by Modulating HAS3 Expression. Cancers, 2021. 13.

4. Brossel, H., Fontaine, A., Hoyos, C., Jamakhani, M., Willems, M., Hamaidia, M., and Willems, L. Activation of DNA Damage Tolerance Pathways May Improve Immunotherapy of Mesothelioma. Cancers, 2021. 13.

5. Johnson, B., Zhuang, L., Rath, E.M., Yuen, M.L., Cheng, N.C., Shi, H., Kao, S., Reid, G., and Cheng, Y.Y. Exploring MicroRNA and Exosome Involvement in Malignant Pleural Mesothelioma Drug Response. Cancers, 2022. 14.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Target Therapy in Malignant Pleural Mesothelioma: Hope or Mirage?;International Journal of Molecular Sciences;2023-05-23